Hema Free Versus Hema Containing Adhesives in Posterior Restorations
Launched by CAIRO UNIVERSITY · Sep 21, 2024
Trial Information
Current as of June 23, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two types of dental adhesives used in fillings for back teeth affected by cavities. The goal is to see how well a new type of adhesive that does not contain HEMA (a specific chemical) performs compared to a traditional adhesive that does contain HEMA over the course of one year. Researchers are using special criteria to evaluate the success of these fillings, ensuring they are effective and safe for patients.
To be eligible for this study, participants should be between 19 and 35 years old and have cavities in their molars that are classified as moderate to severe. However, certain individuals cannot participate, including those who are pregnant, have certain health issues, or have a history of allergies to specific dental materials. If someone joins the trial, they can expect to receive a dental filling using one of the adhesives being tested and will be monitored over the year to assess how well the filling holds up. This research could help improve dental care options in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria of participants:
- • Patients with occlusal caries in molars classified as ICDAS III or IV.
- • 19-35 years.
- • Males or Females.
- • Co-operative patients approving to participate in the trial.
- Exclusion criteria of participants:
- • Pregnancy.
- • Disabilities.
- • Systemic disease or severe medical complications.
- • Allergic history concerning methacrylate.
- • Rampant caries.
- • Heavy smoking.
- • Xerostomia.
- • Lack of compliance.
- • Evidence of severe bruxism, clenching, or tempromandibular joint disorders.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Manyal, Egypt
Patients applied
Trial Officials
Alaa F Abdelsalam, phD
Principal Investigator
lecturer of conservative dentistry, Cairo university
Hadier M Gad, PhD
Principal Investigator
Lecturer of conservative dentistry, Cairo university
Manar A Elmokanen, PhD
Principal Investigator
Lecturer of conservative dentistry, Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported